Unlike in the rest of the country, where intestinal ultrasound rarely is used in the clinic, in New York City, gastroenterologists at Mount Sinai Hospital have made IUS findings the “the fifth vital sign” for inflammatory bowel disease patient care, particularly to monitor disease. Now, new research from the institution and other centers is showing that the tool can identify patients with endoscopic recurrence and possibly predict disease outcomes and treatment response.
Trending
- Physician hiring, turnover increases after practices acquired by private equity, study finds (Fierce Healthcare)
- Supreme Court Case Could Threaten Free Colorectal Cancer Screenings (AJMC)
- Hospitals line up to sue Blue Cross, opting out of $2.8 bln settlement (Reuters)
- ChatGPT Competes With Surgeons in Patient Q&A (Medscape)
- Richard Peek to serve as president of international gastroenterology group (VUMC)
- Medicare To Reimburse Guardant Health’s Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue (Benzinga)
- Why the Hinge Health IPO is so important for digital health (Second Opinion)
- Nine guideline-based best practices for IBS (AGA)